Search results
Results from the WOW.Com Content Network
Flibanserin is the first pharmaceutical product from Sprout Pharmaceuticals [14] for premenopausal women with HSDD. The drug was approved by the FDA in 2015. It compiles a serotonin 1A receptor agonist and a serotonin 2A receptor antagonist. [15] and is an antidepressant [16] that was originally developed for depression. [12]
A New Drug Application of bremelanotide for female sexual dysfunction was accepted by the US Food and Drug Administration (FDA) in June 2018, with a Prescription Drug User Fee Act (PDUFA) goal date set for 23 March 2019. [30] It was approved for use in the United States in June 2019. [3] [31] [32]
The U.S. Food and Drug Administration is asking a panel of experts to weigh in on a women's version of the male sexual dysfunction drug Viagra. The FDA is considering Boehringer Ingelheim's drug ...
In the documentary, filmmaker Liz Canner takes a job editing erotic movies for a drug trial for a pharmaceutical company called Vivus. Her employer is developing what they hope will be the first Viagra drug for women that wins FDA approval to treat a new disease: female sexual dysfunction (FSD). Liz gains permission to film the company's work ...
How Does Herbal Viagra Differ From Real Viagra? Viagra is the brand-name version of a medication called sildenafil citrate. It belongs to a class of drugs called phosphodiesterase 5 inhibitors ...
The pharmaceutical industry has discovered the female libido. German biotech company Boehringer Ingelheim is "putting the finishing touches on a pill designed to reawaken desire by blunting female ...
The PDUFA date serves as a good first approximation of when a final decision on drug approval can be expected. Sponsors frequently publish PDUFA dates for their pending applications, [1] and while there is no official list of PDUFA dates, [10] several websites collect PDUFA dates from press announcements in a calendar form.
For premium support please call: 800-290-4726 more ways to reach us